Turner A G, Carter S, Higgins E, Glashan R W, Neville A M
Br J Urol. 1977 Feb;49(1):61-6. doi: 10.1111/j.1464-410x.1977.tb04525.x.
Plasma and urinary CEA levels in patients presenting with haematuria have been studied to assess whether they facilitate the differentiation between benign and malignant urothelial conditions. Plasma CEA is of no diagnostic value although, if raised, it may suggest an invasive tumour. Urinary CEA levels are only of value in the absence of urinary infection; even then, only 37% of the cases with overt urothelial tumours had raised titres. A knowledge of the urinary CEA level, therefore, would seem to contribute little to the diagnosis of patients presenting with haematuria and all patients must still be investigated by the conventional techniques of urinary bacteriology, cytology, intravenous pyelography and cystourethroscopy.
对出现血尿的患者的血浆和尿液癌胚抗原（CEA）水平进行了研究，以评估它们是否有助于区分良性和恶性尿路上皮疾病。血浆CEA没有诊断价值，不过，如果其水平升高，可能提示存在浸润性肿瘤。尿CEA水平仅在无泌尿系统感染时才有价值；即便如此，在明显的尿路上皮肿瘤病例中，也只有37%的病例其滴度升高。因此，尿CEA水平的信息似乎对血尿患者的诊断帮助不大，所有患者仍必须通过泌尿系统细菌学、细胞学、静脉肾盂造影和膀胱尿道镜检查等传统技术进行检查。
